SOLUBILITY AND DISSOLUTION RATE ENHANCEMENT OF TELMISARTAN BY SOLID DISPERSION AND PELLETIZATION TECHNIQUES USING SOLUPLUS AS CARRIER
Objective: In the present investigation, an attempt was made to improve the surface characters and solubility of the drug by solid dispersion and coating it on the nonpareil sugar beads as pellets.
Methods: Telmisartan solid dispersions were prepared by kneading method using soluplus. Crospovidone was added as disintegrant in pellets. Telmisartan pellets were prepared by dissolving soluplus and crospovidone in ethanol in different ratios and coated on nonpareil sugar beads as a drug layer by pan coating technique. Various physicochemical parameters like particle size, friability, angle of repose and drug content were evaluated for the prepared solid dispersions and pellet formulations. In vitro dissolution studies were carried out in pH 7.5 phosphate buffer using USP apparatus II. Fourier Transform Infrared Spectrometry, Differential Scanning Calorimetry and Scanning Electron Microscopic analysis were performed for solid dispersions, pellet formulations and its polymers to determine the interactions and surface characteristics.
Results: The physicochemical parameters were within the specified I. P limits. It was observed that the solid dispersion formulation TS5 containing 1:5 ratio of telmisartan to soluplus showed better dissolution rate to the extent of 1.143 folds and 2.033 folds when compared to a marketed formulation and the pure drug, respectively. Similarly, pellet formulation TP3 containing 1:3 ratio of telmisartan to soluplus showed an improved dissolution rate to the extent of 1.221 folds and 2.170 folds when compared to the marketed formulation and the pure drug, respectively. FTIR and DSC analysis revealed that there was no major interaction between the drug and the excipients.
Conclusion: From the present study, it was observed that the solubility of telmisartan was enhanced by soluplus in pellet formulations when compared to solid dispersions.
2. Vial Bernasconi AC, Doelker E, Buri P. Prolonged release capsules divided and monolithic forms. STP Pharma Sci 1988;4:397-409.
3. Malinowski HJ, Smith WE. Effect of spheronization process variables on selected tablet properties. J Pharma Sci 1974;63:285-8.
4. Jackson IM, Roberts S, Timmins P, Sen H. Comparison of laboratory scale processing in the production of coated pellets. Pharm Tech Int 1989;1:29-32.
5. Gamlen MJ. Pellet manufacture for controlled release. Manufacturing Chemist; 1985. p. 55-9.
6. Nastruzzi C, Cortesi R, Esposito E, Genovesi A, Spadoni A, Vecchio C, et al. Influence of formulation and process parameters on pellet production by powder layering technique. AAPS PharmSciTech 2000;12:E9.
7. Olsen K. Fluid bed equipment. In: Ghebre Sellassie I. ed. Pharmaceutical Pelletization Technology. Marcel and Dekker, New York; 1989. p. 39-69.
8. Bauer KH, Lehmann K, Osterwald HP, Rothgang G. Equipment for sugar coating and film coating processes coated pharmaceutical dosage forms. Medpharm Scientiphic Publishers, Stuttgart; 1998.
9. Felton LA. Film coating of oral solid dosage form. In: Swarbrick J. ed. Encyclopedia of Pharmaceutical Technology. Informa Healthcare; 2007;3:1729–47.
10. Stangier J, Su CA, Roth W. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients. J Int Med Res 2000;28:149–67.
11. Tirumalesh N, Chowdary KPR. Formulation development and optimization of telmisartan tablets employing ?cd starch 1500 and soluplus. Indo Am J Pharm Sci 2017;4:1630-5.
12. Vinit C, Rohini L, Jyoti S, Minal G, Supriya J. UV spectrophotometric method development and validation for telmisartan in bulk and tablet dosage form. Asian J Pharm Clin Res 2013;6:19-21.
13. Sucheta B, Dyandevi M, Mithun VK, Rajendra DP. Solubility enhancement of anti-hypertensive agent by solid dispersion technique. Int J Pharm Life Sci 2011;2:970–5.
14. Shankarguru P, Ramya Devi D, Vedha Hari BN. Effect of water content in kneading method of solid dispersion technique for solubility enhancement. Int J Appl Pharm 2017;9:14-21.
15. Poonam Arora, Jaspreet Singh, Renu Chadha. Physicochemical characterization and evaluation of telmisartan: hydroxypropyl-?-cyclodextrin: tween 80 inclusion complex. Int J Pharm Pharm Sci 2017;9:51-8.
16. Kausalya J, Suresh K, Padmapriya S, Anusha R, Senthilnathan B. Solubility and dissolution enhancement of telmisartan using various techniques. Int J Pharm Tech Res 2011;3:1737–49.
17. Ashwini K, Santosh S, Vivek R, Yogesh K, Ashish J. Review on antihyperlipidemic lipophilic drugs and their novel formulation approaches. Int J Pharm Pharm Sci 2017;99:1-8.
18. Gordon RE, Rosanske TW, Fonner DE, Anderson NR, Banker GS. Granulation technology and tablet characterization. Pharmaceutical dosage forms: tablets. 1990;2:324.
19. Train D. Some aspects of the property of angle of repose of powders. J Pharm Pharmacol 1958;10(S1).
20. Niranjan C, Anuradha C, Shubahngi S, Jagdish S. Improvement of bioavailability and solubility of telmisartan by solid dispersion technique using various carriers. Int J Pharm Sci Rev Res 2013;19:36–41.
21. Alatas FI, Ratih HE, Soewandhi SN. Enhancement of solubility and dissolution rate of telmisartan by telmisartan-oxalic acid cocrystal formation. Int J Pharm Pharm Sci 2015;7:423-6.
22. Jain AJ, Gohel DK, Patel KN, Patel BA, Patel PA. Use of combined techniques of solubilization for improving solubility and dissolution of immediate release tablet containing telmisartan. Int J Pharm Res Scholars 2012;1:221–31.
23. Venkatarao M, Vidyadhara S, Sandeep D. Formulation and evaluation of telmisartan solid dispersions using entada scandens seed starch and poloxamer-188 as superdisintegrants. Asian J Pharm Clin Res 2018;11:474-81.
This work is licensed under a Creative Commons Attribution 4.0 International License.